Decreased hepatic drug demethylation in patients receiving chemo‐immunotherapy

Allan Lipton, Gershon W. Hepner, Deborah S. White, Harold A. Harvey

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


The effect of immunotherapy and chemotherapy on hepatic N‐demethylation of aminopyrine was studied by means of the aminopyrine breath test (ABT) in 32 patients with cancer. The aminopyrine breath test (ABT) was decreased in 3 of 11 patients (27.3%) receiving intradermal BCG (± DTIC) at a dose of 3 × 107 viable organisms. One of 4 (25%) patients receiving intradermal BCG (± DTIC) at 3 × 108 viable organisms per dose developed an altered ABT. Changes were not seen in patients receiving aerosol BCG (2 patients), intravenous C. parvum (2 patients), subcutaneous C. parvum (3 patients), and intravenous Cyclophosphamide (2 patients). Six of 7 patients (85.7%) receiving both intravenous C. parvum and Cyclophosphamide had a decreased ABT. These data indicate that chemo‐immunotherapy depressed hepatic aminopyrine N‐demethylation and suggests that patients treated with chemoimmunotherapy should be carefully observed for possible alterations of hepatic drug metabolism.

Original languageEnglish (US)
Pages (from-to)1680-1684
Number of pages5
Issue number5
StatePublished - May 1978

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Decreased hepatic drug demethylation in patients receiving chemo‐immunotherapy'. Together they form a unique fingerprint.

Cite this